Home/Filings/4/A/0001628280-23-001321
4/A//SEC Filing

Huber Reid M 4/A

Accession 0001628280-23-001321

CIK 0001358403other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 2:24 PM ET

Size

5.0 KB

Accession

0001628280-23-001321

Insider Transaction Report

Form 4/AAmended
Period: 2023-01-03
Huber Reid M
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-03+80,968146,951 total
Footnotes (1)
  • [F1]This amendment is being filed to correct the mathematical error in the amount of securities acquired and the amount of securities beneficially owned following reported transaction on the original Form 4 filed with the SEC on January 5, 2023.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001607052

Filing Metadata

Form type
4/A
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 2:24 PM ET
Size
5.0 KB